Pediatrix Medical Group, Inc. (NYSE:MD) Short Interest Update

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 1,390,000 shares, a decrease of 28.7% from the April 30th total of 1,950,000 shares. Approximately 1.6% of the company's stock are short sold. Based on an average daily volume of 829,000 shares, the short-interest ratio is currently 1.7 days.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of institutional investors have recently added to or reduced their stakes in the company. Strs Ohio acquired a new stake in Pediatrix Medical Group during the first quarter worth about $690,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Pediatrix Medical Group by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 268,506 shares of the company's stock worth $3,891,000 after buying an additional 12,171 shares in the last quarter. Optimize Financial Inc acquired a new stake in Pediatrix Medical Group during the first quarter worth about $167,000. Empowered Funds LLC lifted its stake in Pediatrix Medical Group by 3.2% during the first quarter. Empowered Funds LLC now owns 289,452 shares of the company's stock worth $4,194,000 after purchasing an additional 9,007 shares during the period. Finally, Aristeia Capital L.L.C. bought a new position in Pediatrix Medical Group during the first quarter worth about $355,000. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD remained flat at $13.90 during midday trading on Thursday. The stock had a trading volume of 557,840 shares, compared to its average volume of 835,902. The firm has a market capitalization of $1.19 billion, a PE ratio of -11.58, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The stock's fifty day moving average is $13.66 and its 200 day moving average is $14.02. Pediatrix Medical Group has a 12 month low of $6.62 and a 12 month high of $17.67. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. During the same period last year, the business earned $0.20 earnings per share. The firm's revenue for the quarter was down 7.4% compared to the same quarter last year. As a group, analysts anticipate that Pediatrix Medical Group will post 1.38 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on MD shares. Macquarie increased their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. UBS Group cut their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a report on Monday, May 12th. Finally, Truist Financial cut their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.